Medicare Enrolled

Dr. Michelle Levin

Endocrinology · Oxnard, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3655 W 5TH ST, Oxnard, CA 93030
8056673909
In practice since 2007 (19 years)
NPI: 1598891368 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levin

Dr. Michelle Levin is an endocrinology specialist in Oxnard, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Levin performed 1,344 Medicare services across 726 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levin received a total of $7,958 from 45 pharmaceutical and/or device companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in CA $7,958 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,344
Medicare services
Top 37% in CA for endocrinology
726
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $79 $160
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
355 $67 $160
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
226 $29 $95
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
193 $7 $50
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
113 $38 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $109 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,958
Total received (2018-2024)
Avg $1,137/year across 7 years
Top 23% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
434
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,946 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$821
2023
$1,081
2022
$1,571
2021
$913
2020
$588
2019
$1,510
2018
$1,473

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$180
Radius Health, Inc.
$110
Amgen Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Abbott Laboratories
$65
Tandem Diabetes Care, Inc.
$56
Lilly USA, LLC
$51
RECORDATI_RARE_DISEASES_INC.
$51
Neurocrine Biosciences, Inc.
$29
ABBVIE INC.
$28
Corcept Therapeutics
$23
Xeris Pharmaceuticals, Inc.
$15
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,145
SANOFI-AVENTIS U.S. LLC
$1,013
Boehringer Ingelheim Pharmaceuticals, Inc.
$839
Amgen Inc.
$494
AstraZeneca Pharmaceuticals LP
$429
Lilly USA, LLC
$405
Radius Health, Inc.
$357
Abbott Laboratories
$211
Tandem Diabetes Care, Inc.
$193
Dexcom, Inc.
$192
Companion Medical, Inc.
$182
Medtronic MiniMed, Inc.
$176
Medtronic, Inc.
$171
Merck Sharp & Dohme Corporation
$102
Xeris Pharmaceuticals, Inc.
$82
Mannkind Corporation
$77
Corcept Therapeutics
$64
Janssen Pharmaceuticals, Inc
$62
ABBVIE INC.
$55
MannKind Corporation
$54
Insulet Corporation
$53
RECORDATI_RARE_DISEASES_INC.
$51
Nevro Corp.
$47
DEXCOM, INC.
$47
Bayer HealthCare Pharmaceuticals Inc.
$44
Amryt Pharma Holdings Ltd
$36
Merz North America, Inc.
$35
PFIZER INC.
$34
Shire North American Group Inc
$33
Neurocrine Biosciences, Inc.
$29
Supernus Pharmaceuticals, Inc.
$24
Orexigen Therapeutics, Inc.
$21
Zealand Pharma US, Inc.
$21
Stryker Corporation
$20
Bioventus LLC
$19
Organon LLC
$18
Ironwood Pharmaceuticals, Inc
$18
Novartis Pharmaceuticals Corporation
$18
Becton, Dickinson and Company
$16
IBSA Pharma Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Regeneron Healthcare Solutions, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Hologic, LLC
$11
Senseonics, Incorporated
$5
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BD Nano · BYDUREON · CONTRAVE · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · Durolane · ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM · ENTRESTO · EVENITY · Enbrel · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LYRICA · LYUMJEV · MAKENA · MINIMED 780G · MYCAPSSA · Minimed 670G System · NEXPLANON · Omnia · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · SYNTHROID · Saxenda · Senza · TOUJEO · TRADJENTA · TROKENDI XR · TRULICITY · TV · Tirosint · Tresiba · Tymlos · UBRELVY · Victoza · Wegovy · XARELTO · XEOMIN · ZEGALOGUE · ZEPBOUND · ZOSTAVAX · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Oxnard?
Compare endocrinologists in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
15
Per 100K population
1.8
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Levin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Levin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Levin performed 423 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levin receive payments from pharmaceutical companies?
Yes. Dr. Levin received a total of $7,958 from 45 companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levin's costs compare to other endocrinologists in Oxnard?
Dr. Levin's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →